Argenx

This study aimed to gather more long-term safety and effectiveness data on the drug efgartigimod for adults with Post-COVID POTS, a condition causing dizziness, fatigue, and a fast heart rate upon standing. It was an extension for 33 people who had finished a prior 24-week study.…

This study tested whether regular injections of an investigational drug called efgartigimod could reduce eye bulging and improve quality of life in adults with active, moderate-to-severe Thyroid Eye Disease. The trial was stopped early because an interim analysis found it was unl…

This study followed adults with moderate-to-severe bullous pemphigoid, a rare autoimmune condition that causes painful skin blisters, to see how safe and effective efgartigimod injections were over a longer period. Participants who completed a previous 36-week study could receive…

This study tested whether regular injections of an experimental drug called efgartigimod could help adults with active, moderate-to-severe Thyroid Eye Disease. The trial compared the drug against placebo injections and measured improvements in eye bulging, double vision, and qual…